LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China · Delayed Price · Currency is CNY 12.95
+0.14 (1.09%)
Aug 3, 2026, 3:00 PM CST
SHA:603883 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,669 | 2,370 | 2,404 | 1,995 | 2,411 | 1,416 |
Short-Term Investments | - | 10.64 | 12.01 | 11.75 | 11.37 | - |
Trading Asset Securities | - | - | - | 1.5 | 3 | 3 |
Cash & Short-Term Investments | 2,669 | 2,380 | 2,416 | 2,008 | 2,425 | 1,419 |
Cash Growth | 10.08% | -1.48% | 20.33% | -17.21% | 70.96% | 0.99% |
Accounts Receivable | 2,071 | 2,171 | 2,432 | 2,312 | 2,183 | 1,421 |
Other Receivables | 183.27 | 29.39 | 94.29 | 116.58 | 49.44 | 339.98 |
Receivables | 2,254 | 2,201 | 2,526 | 2,429 | 2,232 | 1,761 |
Inventory | 3,634 | 3,652 | 3,574 | 4,152 | 3,949 | 2,730 |
Other Current Assets | 461.97 | 597.22 | 557.62 | 540.51 | 856.72 | 318.52 |
Total Current Assets | 9,018 | 8,831 | 9,074 | 9,130 | 9,463 | 6,228 |
Property, Plant & Equipment | 3,334 | 3,399 | 3,976 | 4,141 | 4,174 | 4,671 |
Long-Term Investments | 125.47 | 124.01 | 133.32 | 110.77 | 470.3 | 636.94 |
Goodwill | 5,613 | 5,613 | 5,756 | 5,836 | 5,493 | 3,695 |
Other Intangible Assets | 780.08 | 802.57 | 841.81 | 746.98 | 599.98 | 466.32 |
Long-Term Deferred Tax Assets | 129.4 | 133.97 | 116.7 | 69.5 | 74.62 | 58.62 |
Long-Term Deferred Charges | 599.99 | 624.22 | 734.12 | 735.87 | 687.89 | 683.56 |
Other Long-Term Assets | 307.08 | 317.57 | 412.97 | 461.35 | 434.87 | 518.03 |
Total Assets | 19,907 | 19,845 | 21,045 | 21,231 | 21,397 | 16,958 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6,877 | 6,755 | 6,555 | 6,995 | 6,948 | 4,915 |
Accrued Expenses | 358 | 679.49 | 629.67 | 706.65 | 742.25 | 398.93 |
Short-Term Debt | 498.19 | 697.3 | 1,657 | 799.75 | 766.21 | 1,616 |
Current Portion of Long-Term Debt | 1,377 | 349.72 | 222.96 | 184.98 | 197.47 | 93.68 |
Current Portion of Leases | - | 877.49 | 981.4 | 1,299 | 1,093 | 810.68 |
Current Income Taxes Payable | 137.06 | 65.28 | 84.15 | 85.75 | 93.38 | 65.59 |
Current Unearned Revenue | 192.45 | 234.43 | 213.49 | 247.73 | 234.98 | 123.29 |
Other Current Liabilities | 609.26 | 505.22 | 575.77 | 836.68 | 771.57 | 589.62 |
Total Current Liabilities | 10,050 | 10,164 | 10,920 | 11,155 | 10,846 | 8,613 |
Long-Term Debt | 1,316 | 1,435 | 1,397 | 1,378 | 1,578 | 875.14 |
Long-Term Leases | 1,199 | 1,205 | 1,523 | 1,371 | 1,821 | 2,625 |
Long-Term Unearned Revenue | 9.64 | 10.56 | 12.93 | 15.91 | 19.1 | 22.29 |
Long-Term Deferred Tax Liabilities | 34.64 | 34.74 | 36.7 | 21.24 | 34.5 | 43.65 |
Total Liabilities | 12,609 | 12,849 | 13,889 | 13,942 | 14,300 | 12,179 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 758.89 | 758.89 | 760.23 | 584.93 | 584.9 | 408.67 |
Additional Paid-In Capital | 1,695 | - | - | - | 2,637 | 1,139 |
Retained Earnings | 4,331 | 4,067 | 3,852 | 3,970 | 3,314 | 2,739 |
Treasury Stock | - | - | -16.94 | -43.26 | -42.93 | -13.75 |
Comprehensive Income & Other | 15.23 | 1,710 | 1,986 | 2,189 | 36.83 | 84.21 |
Total Common Equity | 6,799 | 6,535 | 6,581 | 6,701 | 6,530 | 4,358 |
Minority Interest | 499.2 | 460.7 | 575.09 | 587.8 | 567.77 | 421.31 |
Shareholders' Equity | 7,298 | 6,996 | 7,156 | 7,289 | 7,098 | 4,779 |
Total Liabilities & Equity | 19,907 | 19,845 | 21,045 | 21,231 | 21,397 | 16,958 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,390 | 4,564 | 5,781 | 5,033 | 5,456 | 6,021 |
Net Cash (Debt) | -1,722 | -2,184 | -3,365 | -3,025 | -3,031 | -4,602 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.26 | -2.86 | -4.41 | -4.00 | -4.04 | -6.51 |
Filing Date Shares Outstanding | 758.89 | 758.89 | 760.1 | 760.23 | 760.37 | 751.84 |
Total Common Shares Outstanding | 758.89 | 758.89 | 760.23 | 760.41 | 760.37 | 751.84 |
Working Capital | -1,032 | -1,334 | -1,846 | -2,025 | -1,383 | -2,385 |
Book Value Per Share | 8.96 | 8.61 | 8.66 | 8.81 | 8.59 | 5.80 |
Tangible Book Value | 406.17 | 119.83 | -17.11 | 118.39 | 437.32 | 196.25 |
Tangible Book Value Per Share | 0.54 | 0.16 | -0.02 | 0.16 | 0.58 | 0.26 |
Buildings | - | 1,094 | 985.88 | 982.09 | 756.57 | 685.2 |
Machinery | - | 1,044 | 1,077 | 944.47 | 838.03 | 745.53 |
Construction In Progress | - | 1.73 | 107.8 | 75.75 | 160.24 | 132.74 |